Positron emission tomography (PET) imaging commonly uses a glucose-based radiotracer, so medications that alter glucose metabolism can change PET tracer uptake.
October 10, 2025
high
temporal
Explains why metabolic-altering drugs can affect PET scan results.
Use of GLP-1 receptor agonists can produce atypical tracer uptake on PET and CT scans that may mimic disease and therefore has the potential to lead to additional diagnostic tests, incorrect cancer assessments, or delays in treatment.
October 10, 2025
high
temporal
Clinical implication of altered imaging patterns associated with metabolic-effecting medications.
Clinical interpretation of PET and CT images should account for patients' medication use to reduce the risk of misinterpretation and unnecessary procedures.
October 10, 2025
high
temporal
Generalizable guidance for imaging teams when assessing scans from patients on medications that can affect imaging.